OMER and NVO Related Headlines

Go Back

Oct 15, 2025 08:32AM Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

OMER and NVO Related Press Releases

Go Back

OMER and NVO Related SEC Filings

Go Back